When cancer spreads, tiny amounts of cells can break away from tumors and circulate in the bloodstream. A liquid biopsy is a means to detect the presence of cancer by detecting these cancer cells floating in blood samples. However, current state-of-the-art methods have necessitated trained specialists to comb through and review images of thousands
By focusing on a trigger of brain inflammation, scientists are in pursuit of a new drug therapy and now understand why some with a key risk factor for the disease develop dementia. Backed by the combined expertise of three USC schools, scientists are developing a new drug aimed at a previously unexplored biological target in
Researchers from the Keck School of Medicine of USC have developed a blood test that can identify early signs of Alzheimer’s disease by measuring proteins linked to the condition. The new test, known as Penta-Plex Alzheimer’s Disease Capture Sandwich Immunoassay (5ADCSI), detects five biomarkers simultaneously, which is more than existing blood tests, and runs on
Today, a USC-licensed startup that developed an intranasal drug delivery system for brain tumors will be listed for the first time on Nasdaq. To celebrate the direct listing, the USC Stevens Center for Innovation and the startup, NeOnc Technologies Holdings Inc., will ring the opening bell at 9:30 a.m. EDT/6:30 a.m. PDT. NeOnc is based
Congratulations to Dr. Valter Longo, Director of the Longevity Institute at USC and his venture, L-Nutra Inc., a premier nutri-technology company leading longevity science nutrition programs, on the closure of a $47M Series D funding. The round was led by a personal investment from Stephane Bancel, CEO at Moderna Inc., alongside Brentwood Associates, a Los Angeles based middle
Spellcheck for Bias is a digital tool developed by the Geena Davis Institute in partnership with the Signal Analysis and Interpretation Laboratory at USC’s Viterbi School of Engineering.
USC has joined a coalition of 15 leading research universities that aims to boost the transfer of researchers’ patented technologies and inventions to companies.
Epic Sciences and USC Michelson Center Convergent Science Institute in Cancer recently announced a new partnership. The Stevens Center helped Dr. Peter Kuhn with the process of executing the license and collaboration agreement.
Bravemind is a clinical, interactive, virtual reality (VR) based exposure therapy tool being used to assess and treat post-traumatic stress disorder (PTSD).
Dr. Mark E. Thompson with his collaborators at USC and Princeton University developed organic light-emitting diode (OLED) technology that Universal Display Corporation (UDC) has advanced and commercialized into an international business.
USC Stevens Center for Innovation - MC 0705
3720 S Flower Street Floor 3
Los Angeles, CA 90089
USC does not endorse or recommend any company, product, or service mentioned here. This information is not investment advice and should not be relied upon.